Citations

Showing 10 of 108135 citations.

Isolated T‐cell acute lymphoblastic leukemic optic disc infiltration
Fortes, Blake H. , Patnaik, Mrinal M. , Choong, Grace M. , Salomão, Diva R. , Bhatti, M. Tariq , Patnaik, Mrinal , Barkmeier, Andrew J. , Fortes, Blake H , Dalvin, Lauren A. , Hogan, William J.

Mayo Clinic

American Journal of Hematology | September 24, 2021 | Volume: 96 | Issue: 12 | Pages: 1717-1718

10.1002/ajh.26357 | PMID 34559909 Get It

Microsurgical Resection of a Petroclival Epidermoid Cyst Using an Anterior Petrosectomy Approach: 2-Dimensional Operative Video
Vakharia, Kunal , Naylor, Ryan M. , Nassiri, Ashley M. , Driscoll, Colin L. W., Link, Michael J., Vakharia, Kunal V., Link, Michael J.

Mayo Clinic

Operative Neurosurgery | September 24, 2021 | Volume: 21 | Issue: 6 | Pages: E565-E565

10.1093/ons/opab364 | PMID 34560780 Get It

Abstract Epidermoid cysts are rare, benign lesions that result from inclusion of ectodermal elements during neural tube closure. 1 Cysts are composed of desquamated epithelial cells and restrict diffusion on magnetic resonance imaging (MRI). 2,3 Symptoms are attributable to anatomic location. 4,5 In this video, we illustrate the surgical treatment of an epidermoid cyst located in the right cerebellopontine angle, petrous apex, and Meckel's cave. The patient, a 33-yr-old female with right-sided V1 trigeminal hypoesthesia, underwent surveillance imaging for 2 yr. However, she developed progressive V1 and V2 trigeminal hypoesthesia and imaging revealed enlargement of the lesion. Therefore, surgical resection was pursued. The patient consented to the procedure. The patient underwent a right middle fossa craniotomy and anterior petrosectomy. After identifying the greater superficial petrosal nerve and cutting the middle meningeal artery as it exited foramen spinosum, Kawase's triangle was drilled, and the dura over Meckel's cave and the subtemporal dura were opened. The lesion was resected, taking care to preserve the trigeminal nerve and the basilar artery. A retrosigmoid craniotomy was then fashioned. The cyst and its capsule were dissected off the brainstem and cranial nerves utilizing natural corridors between the trigeminal and vestibulocochlear nerves as well as between the facial and lower cranial nerves. Gross total resection was confirmed on postoperative MRI, and she was discharged home on postoperative day 5. Three months after surgery, she underwent formal pinprick testing, which revealed 95% loss of sensation in V1, 20% loss in V2, and normal sensation in V3. Three-month postoperative MRI showed no residual tumor.
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement
Bagley, Stephen , Kothari, Shawn, Rahman, Rifaquat , Lee, Eudocia Q. , Dunn, Gavin P. , Galanis, Evanthia , Chang, Susan M. , Nabors, Burt , Ahluwalia, Manmeet S. , Stupp, Roger , Reardon, David A. , Khagi, Simon , Weller, Michael , Wen, Patrick Y. , Nabors, Louis Burt , Mehta, Minesh P , Sulman, Erik P , Weller, Michael , Khasraw, Mustafa , Galanis, Evanthia , Stupp, Roger , Ahluwalia, Manmeet S , Mehta, Minesh P. , Grossman, Stuart A. , Sulman, Erik P. , Sampson, John Howard , Cloughesy, Timothy F. , Wen, Patrick Yung , Khasraw, Mustafa

Mayo Clinic

Clinical Cancer Research | September 24, 2021 | Volume: 28 | Issue: 4 | Pages: 594-602

10.1158/1078-0432.ccr-21-2750 | PMID 34561269 Get It

Abstract Therapeutic advances for glioblastoma have been minimal over the past 2 decades. In light of the multitude of recent phase III trials that have failed to meet their primary endpoints following promising preclinical and early-phase programs, a Society for Neuro-Oncology Think Tank was held in November 2020 to prioritize areas for improvement in the conduct of glioblastoma clinical trials. Here, we review the literature, identify challenges related to clinical trial eligibility criteria and trial design in glioblastoma, and provide recommendations from the Think Tank. In addition, we provide a data-driven context with which to frame this discussion by analyzing key study design features of adult glioblastoma clinical trials listed on ClinicalTrials.gov as “recruiting” or “not yet recruiting” as of February 2021.
Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease
Keir, Mary , Fuh, Franklin, Ichikawa, Ryan, Acres, Meghan, Hackney, Jason A. , Hulme, Gillian , Carey, Christopher D. , Palmer, Jeremy M. , Jones, Claire , Long, Anna K, Jiang, Jenny , Klabunde, Sha, Mansfield, John , Looney, Cary M., Faubion, William A. , Filby, Andrew , McBride, Jacqueline , Lamb, Christopher A , Keir, Mary E , Palmer, Jeremy , Jones, Claire J , Mansfield, John C , Kirby, John A , McBride, Jacqueline , Lamb, Christopher A , Long, Anna , Kirby, John A.

Mayo Clinic

The Journal of Immunology | September 24, 2021 | Volume: 207 | Issue: 9 | Pages: 2245-2254

10.4049/jimmunol.2100220 | PMID 34561227 Get It

Abstract Targeting interactions between α4β7 integrin and endothelial adhesion molecule MAdCAM-1 to inhibit lymphocyte migration to the gastrointestinal tract is an effective therapy in inflammatory bowel disease (IBD). Following lymphocyte entry into the mucosa, a subset of these cells expresses αEβ7 integrin, which is expressed on proinflammatory lymphocytes, to increase cell retention. The factors governing lymphocyte migration into the intestinal mucosa and αE integrin expression in healthy subjects and IBD patients remain incompletely understood. We evaluated changes in factors involved in lymphocyte migration and differentiation within tissues. Both ileal and colonic tissue from active IBD patients showed upregulation of ICAM-1, VCAM-1, and MAdCAM-1 at the gene and protein levels compared with healthy subjects and/or inactive IBD patients. β1 and β7 integrin expression on circulating lymphocytes was similar across groups. TGF-β1 treatment induced expression of αE on both β7+ and β7− T cells, suggesting that cells entering the mucosa independently of MAdCAM-1/α4β7 can become αEβ7+. ITGAE gene polymorphisms did not alter protein induction following TGF-β1 stimulation. Increased phospho-SMAD3, which is directly downstream of TGF-β, and increased TGF-β–responsive gene expression were observed in the colonic mucosa of IBD patients. Finally, in vitro stimulation experiments showed that baseline β7 expression had little effect on cytokine, chemokine, transcription factor, and effector molecule gene expression in αE+ and αE− T cells. These findings suggest cell migration to the gut mucosa may be altered in IBD and α4β7−, and α4β7+ T cells may upregulate αEβ7 in response to TGF-β once within the gut mucosa.
Designing Clinical Trials for Combination Immunotherapy: A Framework for Glioblastoma
Singh, Kirit , Batich, Kristen A. , Wen, Patrick Y. , Bagley, Stephen , Lim, Michael , Platten, Michael , Colman, Howard , Ashley, David M. , Chang, Susan M. , Rahman, Rifaquat , Mansouri, Alireza , Reardon, David A. , Sahebjam, Solmaz , Simes, John, Berry, Donald A. , Zadeh, Gelareh , Cloughesy, Tim, Piantadosi, Steven , Weller, Michael , Heimberger, Amy B. , Tan, Aaron C. , Platten, Michael , Colman, Howard , Galanis, Evanthia , Berry, Donald , Mehta, Minesh P , Piantadosi, Steven , Weller, Michael , Khasraw, Mustafa , Mansouri, Alireza , Wen, Patrick Yung , Galanis, Evanthia , Puduvalli, Vinay K. , Sampson, John Howard , Mehta, Minesh P. , Heimberger, Amy B. , Khasraw, Mustafa , Simes, Robert John

Mayo Clinic

Clinical Cancer Research | September 24, 2021 | Volume: 28 | Issue: 4 | Pages: 585-593

10.1158/1078-0432.ccr-21-2681 | PMID 34561270 Get It

Abstract Immunotherapy has revolutionized treatment for many hard-to-treat cancers but has yet to produce significant improvement in outcomes for patients with glioblastoma. This reflects the multiple and unique mechanisms of immune evasion and escape in this highly heterogeneous tumor. Glioblastoma engenders profound local and systemic immunosuppression and is remarkably effective at inducing T-cell dysfunction, posing a challenge to any immunotherapy-based approach. To overcome these mechanisms, multiple disparate modes of immune-oriented therapy will be required. However, designing trials that can evaluate these combinatorial approaches requires careful consideration. In this review, we explore the immunotherapy resistance mechanisms that have been encountered to date and how combinatorial approaches may address these. We also describe the unique aspects of trial design in both preclinical and clinical settings and consider endpoints and markers of response best suited for an intervention involving multiple agents.
Cognitive Predictors of Social Adjustment in Pediatric Brain Tumor Survivors Treated with Photon versus Proton Radiation Therapy
Warren, Emily , Child, Amanda , Grosshans, David R. , Paulino, Arnold, Okcu, M. Fatih , Ris, D., Mahajan, Anita , Chintagumpala, Murali , Paulino, Arnold C. , Paulino, Arnold C , Raghubar, Kimberly P , Cirino, Paul T. , Minard, Charles G. , Viana, Andres G. , Kahalley, Lisa S.

Mayo Clinic

No container title available | September 24, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.22541/au.163251511.16879224/v1 Get It

Background: Pediatric brain tumor survivors are at risk for poor social outcomes. It remains unknown whether cognitive sparing with proton radiotherapy (PRT) supports better social outcomes relative to photon radiotherapy (XRT). We hypothesized that survivors treated with PRT would outperform those treated with XRT on measures of cognitive and social outcomes. Further, we hypothesized that cognitive performance would predict survivor social outcomes. Procedure: Survivors who underwent PRT (n=38) or XRT (n=20) participated in a neurocognitive evaluation >1 year post-radiotherapy. Group differences in cognitive and social functioning were assessed using ANCOVA. Regression analyses examined predictors of peer relations and social skills. Results: Age at evaluation, radiation dose, tumor diameter, and sex did not differ between groups (all p>0.05). However, XRT participants were younger at diagnosis (XRT M=5.0 years, PRT M=7.6 years) and further out from radiotherapy (XRT M=8.7 years, PRT M=4.6 years). The XRT group performed worse than the PRT group on measures of processing speed (p=0.01) and verbal memory (p<0.01); however, social outcomes did not differ by radiation type. The proportion of survivors with impairment in peer relations and social skills exceeded expectation (2(1)=38.67, p<0.001; 2(1)=5.63, p<0.05), and verbal memory approached significance as a unique predictor of peer relations (t=-2.01, p=0.05). Total tumor RT dose significantly predicted social skills (t=-2.23, p<0.05). Conclusions: Regardless of radiation modality, survivors are at risk for social challenges, with one-quarter being socially excluded or undervalued. Deficits in verbal memory may place survivors at particular risk. Results support monitoring of cognitive and social functioning throughout survivorship.
Comminuted Distal Radius Fracture with Concomitant Median Nerve Transection
Mead, Kelly C. , Sgromolo, Nicole M., Krueger, Chad A. , Rhee, Peter C.

Mayo Clinic

JBJS Case Connector | September 24, 2021 | Volume: 11 | Issue: 3 | Pages: No page available

10.2106/jbjs.cc.21.00273 | PMID 34559735 Get It

Case: A 41-year-old woman sustained a distal radius fracture with concomitant median nerve transection. The wound was consistent with an inside-to-outside mechanism with noted metaphyseal bone loss at the level of the median nerve injury. The median nerve was not amenable to primary repair, and given concern for inability to define the zone of the injury, the patient underwent delayed reconstruction of the nerve. Conclusion: A review of the literature highlights the rare incidence of this combined injury that can be undetected or misdiagnosed as an acute carpal tunnel syndrome or stretch injury to the median nerve.
Preintervention imaging and intraoperative management care of the hypertrophic obstructive cardiomyopathy patient
Garijo, Jacobo Moreno , Perdomo, Juan , Meineri, Massimiliano , Moreno Garijo, Jacobo , Abel, Martin D, Ibáñez, Cristina , Abel, Martin

Mayo Clinic

Asian Cardiovascular and Thoracic Annals | September 24, 2021 | Volume: 30 | Issue: 1 | Pages: 35-42

10.1177/02184923211047126 | PMID 34558997 Get It

With an estimated overall mortality of less than 1 percent per year, hypertrophic cardiomyopathy, is the most common genetic cardiomyopathy. Intraoperative transesophageal echocardiography is the standard of care for assessing patients with hypertrophic obstructive cardiomyopathy undergoing surgical septal myectomy, allowing surgical planning, intraoperative hemodynamic monitoring, and postprocedural assessment of the repair, including detection of immediate complications. At various phases during surgical septal myectomy, the changing hemodynamic conditions may lead to worsening or improvement in left ventricle outflow tract obstruction by change in preload or afterload, systolic anterior motion of the mitral valve, or sympathetic stimulation. These characteristics represent unique challenges in the management of these patients, requiring a comprehensive understanding of the management of all the conditions required to decrease the left ventricle outflow tract gradient avoiding obstruction, which include the maintenance of sinus rhythm, adequate rate avoiding tachycardia and bradycardia, and avoidance of systemic hypotension preserving preload and afterload, with adequate vasoactive agents. The aim of this review is to summarize the perioperative assessment and management of patients undergoing hypertrophic obstructive myopathy surgery.
Titanium Cervical Cage Subsidence: Postoperative Computed Tomography Analysis Defining Incidence and Associated Risk Factors
Pinter, Zachariah W. , Reed, Ryder, Townsley, Sarah E., Mikula, Anthony L. , Dittman, Lauren E. , Xiong, Ashley , Skjaerlund, Jonathan, Michalopoulos, Giorgos D. , Currier, Bradford L. , Fogelson, Jeremy L. , Freedman, Brett A. , Bydon, Mohamad , Kepler, Christopher K. , Wagner, Scott C. , Elder, Benjamin D. , Sebastian, Arjun S. , Dittman, Lauren, Freedman, Brett A , Bydon, Mohamad , Michalopoulos, Giorgos , Nassr, Ahmad

Mayo Clinic

Global Spine Journal | September 24, 2021 | Volume: 13 | Issue: 7 | Pages: 1703-1715

10.1177/21925682211046897 | PMID 34558320 Get It

Study Design Retrospective cohort study Objective Substantial variability in both the measurement and classification of subsidence limits the strength of conclusions that can be drawn from previous studies. The purpose of this study was to precisely characterize patterns of cervical cage subsidence utilizing computed tomography (CT) scans, determine risk factors for cervical cage subsidence, and investigate the impact of subsidence on pseudarthrosis rates. Methods We performed a retrospective review of patients who underwent one- to three-levels of anterior cervical discectomy and fusion (ACDF) utilizing titanium interbodies with anterior plating between the years 2018 and 2020. Subsidence measurements were performed by two independent reviewers on CT scans obtained 6 months postoperatively. Subsidence was then classified as mild if subsidence into the inferior and superior endplate were both ≤2 mm, moderate if the worst subsidence into the inferior or superior endplate was between 2 to 4 mm, or severe if the worst subsidence into the inferior or superior endplate was ≥4 mm. Results A total of 51 patients (100 levels) were included in this study. A total of 48 levels demonstrated mild subsidence (≤2 mm), 38 demonstrated moderate subsidence (2-4 mm), and 14 demonstrated severe subsidence (≥4 mm). Risk factors for severe subsidence included male gender, multilevel constructs, greater mean vertebral height loss, increased cage height, lower Taillard index, and lower screw tip to vertebral body height ratio. Severe subsidence was not associated with an increased rate of pseudarthrosis. Conclusion Following ACDF with titanium cervical cages, subsidence is an anticipated postoperative occurrence and is not associated with an increased risk of pseudarthrosis.